Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study: Figure 1. | Zendy

Florian Kurth | Zendy; M. Develoux | Zendy; M. Méchain | Zendy; Jan Clerinx | Zendy; Spinello Antinori | Zendy; Ida Gjørup | Zendy; Joaquím Gascón | Zendy; Kristine Mørch | Zendy; Emanuele Nicastri | Zendy; Michael Ramharter | Zendy; Alessandro Bartoloni | Zendy; Leo G. Visser | Zendy; Thierry Rolling | Zendy; Philipp Zanger | Zendy; Guido Calleri | Zendy; Joaquín Salas-Coronas | Zendy; Henrik Nielsen | Zendy; G. JustNübling | Zendy; Andreas Neumayr | Zendy; Anna Hachfeld | Zendy; Matthias L. Schmid | Zendy; Pietro Antonini | Zendy; Peter Pongratz | Zendy; Peter Kern | Zendy; José Saraiva da Cunha | Zendy; Antoni SorianoArandes | Zendy; Mirjam Schunk | Zendy; Norbert Suttorp | Zendy; Christoph Hatz | Zendy; Thomas Zöller | Zendy

Open Access

Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study: Figure 1.

Author(s) -

Florian Kurth,

M. Develoux,

M. Méchain,

Jan Clerinx,

Spinello Antinori,

Ida Gjørup,

Joaquím Gascón,

Kristine Mørch,

Emanuele Nicastri,

Michael Ramharter,

Alessandro Bartoloni,

Leo G. Visser,

Thierry Rolling,

Philipp Zanger,

Guido Calleri,

Joaquín Salas-Coronas,

Henrik Nielsen,

G. JustNübling,

Andreas Neumayr,

Anna Hachfeld,

Matthias L. Schmid,

Pietro Antonini,

Peter Pongratz,

Peter Kern,

José Saraiva da Cunha,

Antoni SorianoArandes,

Mirjam Schunk,

Norbert Suttorp,

Christoph Hatz,

Thomas Zöller

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ575

Subject(s) - artesunate , medicine , malaria , severe malaria , quinine , intensive care unit , artemisinin , plasmodium falciparum , intensive care medicine , immunology

Intravenous artesunate improves survival in severe malaria, but clinical trial data from nonendemic countries are scarce. The TropNet severe malaria database was analyzed to compare outcomes of artesunate vs quinine treatment. Artesunate reduced parasite clearance time and duration of intensive care unit and hospital treatment in European patients with imported severe malaria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research